Melanie Rolli

Melanie Rolli has an extensive work experience in various roles and positions. Melanie currently holds the position of Chief Executive Officer at Helsinn Group since January 2023. Prior to this, they served as the Chief Operating Officer at Helsinn Group from June 2022 to December 2022.

Melanie has also worked as a Non Executive Director at Baccinex since November 2020 and at ERYTECH Pharma from March 2020 to May 2023. Melanie held the role of Non Executive Director at Rivia from December 2021 to December 2022.

Previously, Melanie was the Chief Executive Officer at AELIX Therapeutics from April 2021 to December 2021. Melanie also held multiple positions at PIQUR Therapeutics AG, including Chief Executive Officer from May 2019 to April 2021, Chief Operating Officer from June 2018 to April 2019, and Chief Medical Officer from March 2017 to April 2019.

Before joining PIQUR Therapeutics AG, they had various roles at Novartis, including Global Head Medical Safety, Group Drug Development from July 2016 to March 2017. Melanie was also the Global Head Integrated Medical Safety, Oncology from August 2014 to July 2016 and the Therapeutic Area Safety Leader_Critical Care, Drug Safety and Epidemiology, VP from January 2013 to August 2014.

Melanie'swork at Novartis also included roles like Chief Scientific Officer a.i. GEM, Head of Medical Affairs, Group Emerging Markets, and Different Global and Local Roles from 2003 to 2011.

Melanie Rolli started their career as a Research Fellow at The Scripps Research Institute from 2001 to 2003. Melanie also participated in a Women's luncheon at GLG Institute in 2014.

Melanie Rolli earned their Medical Doctor degree with a specialization in Gyn/Obs and Pharmacology at Heidelberg University from 1992 to 1999. Melanie then pursued a postdoctoral research position at Scripps Research from 2001 to 2003, specializing in MEM. In 2015, they attended Harvard Business School Executive Education, earning a degree in Finance for non-financial professionals. Recently, in 2021, they completed an Executive Education program in Business Administration and Management, General at Imperial College London.